Womfly 1200 Tablet contains Albendazole 1200 mg, a high-dose, broad-spectrum anthelmintic formulation designed for the management of severe, resistant, or systemic parasitic worm infestations under strict medical supervision.
Albendazole works by disrupting microtubule formation and inhibiting glucose uptake in parasites, leading to energy depletion and irreversible parasite death. The higher dosage strength is particularly useful in complex helminthic infections, including neurocysticercosis, hydatid disease, and heavy intestinal worm burden, where enhanced therapeutic exposure is required.
Clinically, this tablet plays a crucial role in comprehensive deworming protocols, parasite load reduction, and prevention of infection-related complications, ensuring improved patient outcomes. The formulation offers precise dosing, consistent bioavailability, and dependable pharmacological action.
Womfly 1200 Tablet is suitable for tertiary care hospitals, specialty clinics, infectious disease centers, government health programs, and institutional supply chains, where high-strength anthelmintic therapy is indicated.